Logo image of RUN

SUNRUN INC (RUN) Stock Fundamental Analysis

NASDAQ:RUN - Nasdaq - US86771W1053 - Common Stock - Currency: USD

8.9  +0.1 (+1.14%)

After market: 8.99 +0.09 (+1.01%)

Fundamental Rating

2

RUN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 93 industry peers in the Electrical Equipment industry. RUN may be in some trouble as it scores bad on both profitability and health. RUN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

RUN had negative earnings in the past year.
RUN had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RUN reported negative net income in multiple years.
RUN had a negative operating cash flow in each of the past 5 years.
RUN Yearly Net Income VS EBIT VS OCF VS FCFRUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1B -2B -3B

1.2 Ratios

RUN has a better Return On Assets (-1.73%) than 63.04% of its industry peers.
The Return On Equity of RUN (-7.25%) is better than 61.96% of its industry peers.
Industry RankSector Rank
ROA -1.73%
ROE -7.25%
ROIC N/A
ROA(3y)-2.48%
ROA(5y)-1.64%
ROE(3y)-9.79%
ROE(5y)-5.9%
ROIC(3y)N/A
ROIC(5y)N/A
RUN Yearly ROA, ROE, ROICRUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30

1.3 Margins

The Gross Margin of RUN (13.02%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of RUN has declined.
The Profit Margin and Operating Margin are not available for RUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.06%
GM growth 5Y-24.6%
RUN Yearly Profit, Operating, Gross MarginsRUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

More info and screens

1

2. Health

2.1 Basic Checks

RUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
RUN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RUN has been increased compared to 5 years ago.
The debt/assets ratio for RUN is higher compared to a year ago.
RUN Yearly Shares OutstandingRUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
RUN Yearly Total Debt VS Total AssetsRUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

RUN has an Altman-Z score of 0.00. This is a bad value and indicates that RUN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.00, RUN perfoms like the industry average, outperforming 47.83% of the companies in the same industry.
RUN has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
RUN's Debt to Equity ratio of 2.33 is on the low side compared to the rest of the industry. RUN is outperformed by 79.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF N/A
Altman-Z 0
ROIC/WACCN/A
WACC5.73%
RUN Yearly LT Debt VS Equity VS FCFRUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.47 indicates that RUN should not have too much problems paying its short term obligations.
RUN's Current ratio of 1.47 is on the low side compared to the rest of the industry. RUN is outperformed by 65.22% of its industry peers.
RUN has a Quick Ratio of 1.15. This is a normal value and indicates that RUN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of RUN (1.15) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.15
RUN Yearly Current Assets VS Current LiabilitesRUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

RUN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.91%, which is quite impressive.
The Revenue for RUN has decreased by -13.46% in the past year. This is quite bad
RUN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.35% yearly.
EPS 1Y (TTM)66.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.48%
Revenue 1Y (TTM)-13.46%
Revenue growth 3Y34.82%
Revenue growth 5Y24.35%
Sales Q2Q%-4.62%

3.2 Future

Based on estimates for the next years, RUN will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.40% on average per year.
The Revenue is expected to grow by 9.18% on average over the next years. This is quite good.
EPS Next Y95.07%
EPS Next 2Y37.95%
EPS Next 3Y24.35%
EPS Next 5Y15.4%
Revenue Next Year-9.48%
Revenue Next 2Y1.09%
Revenue Next 3Y5.71%
Revenue Next 5Y9.18%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RUN Yearly Revenue VS EstimatesRUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
RUN Yearly EPS VS EstimatesRUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RUN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RUN Price Earnings VS Forward Price EarningsRUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RUN Per share dataRUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as RUN's earnings are expected to grow with 24.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.95%
EPS Next 3Y24.35%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RUN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNRUN INC

NASDAQ:RUN (2/4/2025, 8:05:54 PM)

After market: 8.99 +0.09 (+1.01%)

8.9

+0.1 (+1.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-27 2025-02-27/amc
Inst Owners117.14%
Inst Owner Change-0.15%
Ins Owners2.5%
Ins Owner Change-1.07%
Market Cap2.00B
Analysts73.13
Price Target17.4 (95.51%)
Short Float %21.83%
Short Ratio5.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)54.58%
Min EPS beat(2)-157.51%
Max EPS beat(2)266.67%
EPS beat(4)2
Avg EPS beat(4)-81.56%
Min EPS beat(4)-448.61%
Max EPS beat(4)266.67%
EPS beat(8)4
Avg EPS beat(8)-304.02%
EPS beat(12)6
Avg EPS beat(12)-221.36%
EPS beat(16)8
Avg EPS beat(16)-151.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-5.73%
Max Revenue beat(2)0.68%
Revenue beat(4)1
Avg Revenue beat(4)-2.95%
Min Revenue beat(4)-5.73%
Max Revenue beat(4)0.68%
Revenue beat(8)3
Avg Revenue beat(8)-0.99%
Revenue beat(12)7
Avg Revenue beat(12)3.88%
Revenue beat(16)11
Avg Revenue beat(16)4.15%
PT rev (1m)-6.76%
PT rev (3m)-24.23%
EPS NQ rev (1m)19.09%
EPS NQ rev (3m)44.11%
EPS NY rev (1m)15.03%
EPS NY rev (3m)-89.34%
Revenue NQ rev (1m)-3.51%
Revenue NQ rev (3m)-10.53%
Revenue NY rev (1m)-0.77%
Revenue NY rev (3m)-2.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.98
P/FCF N/A
P/OCF N/A
P/B 0.38
P/tB 0.93
EV/EBITDA N/A
EPS(TTM)-1.82
EYN/A
EPS(NY)-0.72
Fwd EYN/A
FCF(TTM)-14.21
FCFYN/A
OCF(TTM)-2.78
OCFYN/A
SpS9.07
BVpS23.53
TBVpS9.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.73%
ROE -7.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.02%
FCFM N/A
ROA(3y)-2.48%
ROA(5y)-1.64%
ROE(3y)-9.79%
ROE(5y)-5.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.06%
GM growth 5Y-24.6%
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 426.35%
Cap/Sales 125.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.15
Altman-Z 0
F-Score3
WACC5.73%
ROIC/WACCN/A
Cap/Depr(3y)456.97%
Cap/Depr(5y)443.83%
Cap/Sales(3y)102.26%
Cap/Sales(5y)101.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.48%
EPS Next Y95.07%
EPS Next 2Y37.95%
EPS Next 3Y24.35%
EPS Next 5Y15.4%
Revenue 1Y (TTM)-13.46%
Revenue growth 3Y34.82%
Revenue growth 5Y24.35%
Sales Q2Q%-4.62%
Revenue Next Year-9.48%
Revenue Next 2Y1.09%
Revenue Next 3Y5.71%
Revenue Next 5Y9.18%
EBIT growth 1Y21.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.49%
EBIT Next 3Y30.33%
EBIT Next 5Y19.53%
FCF growth 1Y-13.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.43%
OCF growth 3YN/A
OCF growth 5YN/A